Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin in Chronic Pancreatitis
NCT05771675Phase 1Recruiting
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Oct 2024
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in chronic pancreatitis (CP) and acute pancreatitis (AP) comparing Simvastatin with Placebo (2 arms). Primary endpoint: Feasibility and Acceptability of Testing Simvastatin at 12 months. Started Oct 2024; status: recruiting.
02
Drugs
simvastatin
03
Conditions
chronic pancreatitis (CP)acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT05771675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05771675.